跳至主要内容
临床试验/NCT03430817
NCT03430817已完成4 期

Citicholine-Amantadine Trial in Traumatic Brain Injury

Ain Shams University1 个研究点 分布在 1 个国家目标入组 45 人开始时间: 2017年12月7日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
45
试验地点
1
主要终点
Galsgow coma scale

研究概览

简要总结

This randomized study aims at comparing between the effects of amantadine, citcholine and its combinations on arousal and behavioral consequences in early phase of moderate Traumatic Brain injury (TBI).

详细描述

As both agents amantadine and citcholine showed considerable effects on neuro-recovery from TBI, The investigators hypothesized that combination therapy of both drugs will have significant effect as it simultaneously will target multiple mechanisms of injury. So, this randomized study aims at comparing between the effects of amantadine, citcholine and their combinations on arousal and behavioral consequences in early phase of moderate TBI

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
16 Years 至 65 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Sustained moderate non-penetrating TBI with GCS of 9-12

排除标准

  • Patients with mild (GCS > 12) or severe TBI (GCS < 9)
  • Patients suffering from any central nervous system disability prior to the traumatic brain injury
  • Major medical problems as; major cardiovascular disease or heart failure, renal insufficiency (creatinine clearance, less than 60 ml per minute), liver impairment,
  • Pregnancy,
  • More than one seizure in the previous month,
  • Prior treatment with amantadine,
  • Allergy to the study drugs.

研究组 & 干预措施

Group C

Experimental

Citicholine Drug

干预措施: Citicholine (Drug)

Group A

Experimental

Amantadine Drug

干预措施: Amantadine (Drug)

Group D

Experimental

Both Citocholine and Amantadine

干预措施: Citicholine (Drug)

Group D

Experimental

Both Citocholine and Amantadine

干预措施: Amantadine (Drug)

结局指标

主要结局

Galsgow coma scale

时间窗: 30 days

Neurological scale which aims to give a reliable and objective way of recording the conscious state of a person for initial as well as subsequent assessment. A patient is assessed against the criteria of the scale, and the resulting points give a patient score between 3 (indicating deep unconsciousness) and 15 (full conscious).

次要结局

  • disability rating scale (DRS)(30 days)
  • Mini Mental scale (MMS)(30 days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Dina Salah Eldin Mahmoud Badre

Assistant Professor

Ain Shams University

研究点 (1)

Loading locations...

相似试验